Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of pancrelipase microtablets in infants and toddlers with cystic fibrosis-related pancreatic insufficiency
2005-001438-34Phase 2Completed
- Sponsor
- McNeil Consumer Healthcare
- Start
- Jul 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of pancrelipase in cystic fibrosis (CF), exocrine pancreatic insufficiency (EPI) and fat malabsorption (4 arms), sponsored by McNeil Consumer Healthcare. Primary endpoints: Safety of pancrelipase microtablets, Palatability of pancrelipase microtablets and 1 more. Started Jul 2005; status: completed.
02
Drugs
pancrelipase
03
Conditions
cystic fibrosis (CF)exocrine pancreatic insufficiency (EPI)fat malabsorption
Beyond the preview
Go deeper on 2005-001438-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001438-34.